Unknown

Dataset Information

0

A novel serum metabolomics-based diagnostic approach for colorectal cancer.


ABSTRACT:

Background

To improve the quality of life of colorectal cancer patients, it is important to establish new screening methods for early diagnosis of colorectal cancer.

Methodology/principal findings

We performed serum metabolome analysis using gas-chromatography/mass-spectrometry (GC/MS). First, the accuracy of our GC/MS-based serum metabolomic analytical method was evaluated by calculating the RSD% values of serum levels of various metabolites. Second, the intra-day (morning, daytime, and night) and inter-day (among 3 days) variances of serum metabolite levels were examined. Then, serum metabolite levels were compared between colorectal cancer patients (N?=?60; N?=?12 for each stage from 0 to 4) and age- and sex-matched healthy volunteers (N?=?60) as a training set. The metabolites whose levels displayed significant changes were subjected to multiple logistic regression analysis using the stepwise variable selection method, and a colorectal cancer prediction model was established. The prediction model was composed of 2-hydroxybutyrate, aspartic acid, kynurenine, and cystamine, and its AUC, sensitivity, specificity, and accuracy were 0.9097, 85.0%, 85.0%, and 85.0%, respectively, according to the training set data. In contrast, the sensitivity, specificity, and accuracy of CEA were 35.0%, 96.7%, and 65.8%, respectively, and those of CA19-9 were 16.7%, 100%, and 58.3%, respectively. The validity of the prediction model was confirmed using colorectal cancer patients (N?=?59) and healthy volunteers (N?=?63) as a validation set. At the validation set, the sensitivity, specificity, and accuracy of the prediction model were 83.1%, 81.0%, and 82.0%, respectively, and these values were almost the same as those obtained with the training set. In addition, the model displayed high sensitivity for detecting stage 0-2 colorectal cancer (82.8%).

Conclusions/significance

Our prediction model established via GC/MS-based serum metabolomic analysis is valuable for early detection of colorectal cancer and has the potential to become a novel screening test for colorectal cancer.

SUBMITTER: Nishiumi S 

PROVIDER: S-EPMC3394708 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background</h4>To improve the quality of life of colorectal cancer patients, it is important to establish new screening methods for early diagnosis of colorectal cancer.<h4>Methodology/principal findings</h4>We performed serum metabolome analysis using gas-chromatography/mass-spectrometry (GC/MS). First, the accuracy of our GC/MS-based serum metabolomic analytical method was evaluated by calculating the RSD% values of serum levels of various metabolites. Second, the intra-day (morning, dayti  ...[more]

Similar Datasets

| S-EPMC5891204 | biostudies-literature
| S-EPMC6934557 | biostudies-literature
| S-EPMC6838203 | biostudies-literature
| S-EPMC4852935 | biostudies-literature
| S-EPMC8353147 | biostudies-literature
| S-EPMC5899358 | biostudies-literature
| S-EPMC5561924 | biostudies-other
| S-EPMC8670180 | biostudies-literature
| S-EPMC8878838 | biostudies-literature
| S-EPMC6794610 | biostudies-literature